patent.fyi
Applications  /  US 2026/0355166
United States Patent Application Publication

US 2026/0355166 A1

Published
Nov 12, 2026
Filed
Sep 11, 2023
Earliest date on the face
Sep 10, 2022
Classification
A61K 31/438
First published here
Nov 19, 2026

Generated automatically. Not reviewed by a person. Not legal advice or an opinion.

Section 1 · machine-generated

What if?

Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.

No entries.

Section 2 · machine-generated

Variations

Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.

Other field of use

Reference standards for wastewater analysis

A purified 2-substituted piperidine derivative serves as a reference standard for measuring the same compound in wastewater. A dilution series is prepared in treated wastewater verified to be free of the target compound and processed alongside the samples. Liquid chromatography coupled to mass spectrometry measures the peak areas, and the calibration curve converts sample peak areas to concentrations.

Component substitution

Mannitol filler for powder capsules

Mannitol replaces lactose as the filler in a hard capsule formulation containing a powdered 2-substituted piperidine derivative. The active powder is mixed with an equal mass of mannitol, and additional mannitol is incorporated in successive portions to reach the target fill mass. The blend is dispensed into capsule shells, and samples from the filling run are assayed for content uniformity.

Parameter or scale variation

Three strengths from one powder blend

A formulation screen uses a powder blend containing 50 milligrams of a 2-substituted piperidine derivative per gram. The blend is dispensed at fill masses of 100, 200, and 400 milligrams into capsule shells sized for each fill. These fill masses yield nominal contents of 5, 10, and 20 milligrams per capsule, respectively, and assay measurements verify the contents.

Temperature cycling of aqueous suspensions

Sealed vials containing an aqueous suspension of a 2-substituted piperidine derivative undergo three temperature cycles, each with 24 hours at 5 degrees Celsius followed by 24 hours at 40 degrees Celsius. Matched vials from the same batch are held at 25 degrees Celsius for the same duration. At the end of the test, microscopy and laser diffraction measure crystal morphology and particle size, and a fixed number of vial inversions measures redispersion.

Combination with existing systems

Solid phase extraction with chromatography

An offline solid phase extraction manifold prepares plasma samples for liquid chromatography coupled to mass spectrometry. For a basic 2-substituted piperidine derivative, acidified plasma is loaded onto a conditioned mixed-mode cation-exchange cartridge, where the protonated analyte binds to the sorbent. A wash removes matrix components, and an alkaline organic eluent releases the analyte. The eluate is evaporated and reconstituted in the starting mobile phase before injection.

Automated or data-driven variant

Automated ph solubility profiling

A liquid handler dispenses buffers at pH 3, 5, 7, and 9 into wells preloaded with excess solid 2-substituted piperidine derivative. A plate shaker mixes the wells at 25 degrees Celsius, and replicate wells are sampled at successive time points to check for a concentration plateau. The liquid handler transfers clarified samples to an autosampler plate, and software calculates dissolved concentrations from chromatographic peak areas using a calibration curve.

Cite aspatent.fyi, US 2026/0355166 A1, claim 1, first published 2026-11-19T09:07:06-05:00, https://patent.fyi/US20260355166/, SHA-256 b8c131b93cb0eefa93004915f5bae07df557d8f19c48fb6b34c2251a370f9956
First published
Permanent addresshttps://patent.fyi/US20260355166/
Content fingerprint (SHA-256)b8c131b93cb0eefa93004915f5bae07df557d8f19c48fb6b34c2251a370f9956
Methodv2026-11-18.2 · automated, not reviewed by a person
Correctionscorrections@patent.fyi